Literature DB >> 27921326

Correlation of genetic results with testicular histology, hormones and sperm retrieval in nonobstructive azoospermia patients with testis biopsy.

W Liu1, X Gao1, G Ma1, L Yan1, T Chen1, T Li1, R-M Yu1, J-L Ma1.   

Abstract

To investigate the frequency and types of genetic results in different testicular histology of patients with nonobstructive azoospermia (NOA), and correlated with hormones and sperm retrieval (SR), a retrospective study was conducted in 286 Chinese NOA patients who underwent testis biopsy and 100 age-matched fertile men as the control group. Chromosome karyotype analyses were performed by the peripheral blood chromosome G-band detection method. Screening of Y chromosome microdeletions of azoospermia factor (AZF) region was performed by polymerase chain reaction (PCR) amplification of 11 sequence-tagged sites (STS). The serum levels of follicle-stimulating hormone, luteinising hormone and testosterone (T) and the appearance of scrotal ultrasound were also obtained. In 286 cases of NOA, 14.3% were found to have chromosomal alterations. The incidence of chromosomal abnormality was 2.8%. Sex chromosomal abnormalities were seen in six cases (four cases of Klinefelter's syndrome (47, XXY) and two cases of mosaics). The incidence of polymorphic chromosomal variants was 3% in the normal group and 11.5% in the NOA group. In total, 15.7% of NOA patients were found to have AZF microdeletions and AZF (c + d) was the most frequent one. The results of hormone and SR were found to be significantly different among all testicular histological types, whereas no significant differences were found when it comes to genetic alterations. It is concluded that the rate of cytogenetic alterations was high in NOA patients. So screening for chromosomal alterations and AZF microdeletions would add useful information for genetic counselling in NOA patients with testis biopsy and avoid vertical transmission of genetic defects by assisted reproductive technology.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  Y chromosome microdeletions of azoospermia factor; chromosomal abnormality; male infertility; nonobstructive azoospermia; testis biopsy

Mesh:

Substances:

Year:  2016        PMID: 27921326     DOI: 10.1111/and.12705

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  6 in total

1.  NBMA Promotes Spermatogenesis by Mediating Oct4 Pathway.

Authors:  Jinfei Yang; Dengfeng Lin; Weiwei Yao; Damin Yun; Liwei Zhou; Sheng Gao; Fei Sun
Journal:  ChemistryOpen       Date:  2022-02-09       Impact factor: 2.630

2.  ICSI outcomes for infertile men with severe or complete asthenozoospermia.

Authors:  Tong Chen; Demin Fan; Xianlong Wang; Changlin Mao; Yaru Chu; Haobo Zhang; Wen Liu; Sentai Ding; Qingyong Liu; Mingzhen Yuan; Jiaju Lu
Journal:  Basic Clin Androl       Date:  2022-04-05

3.  Aberrant Gene Expression Profiling in Men With Sertoli Cell-Only Syndrome.

Authors:  Tong Chen; Yichun Wang; Linlin Tian; Xuejiang Guo; Jiadong Xia; Zengjun Wang; Ninghong Song
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 4.  Endocrine aberrations of human nonobstructive azoospermia.

Authors:  Yong Tao
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

5.  Mechanisms of the Testis Toxicity Induced by Chronic Exposure to Mequindox.

Authors:  Qianying Liu; Zhixin Lei; Anxiong Huang; Qirong Lu; Xu Wang; Saeed Ahmed; Ihsan Awais; Zonghui Yuan
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810

6.  Toxic metabolites, Sertoli cells and Y chromosome related genes are potentially linked to the reproductive toxicity induced by mequindox.

Authors:  Qianying Liu; Zhixin Lei; Menghong Dai; Xu Wang; Zonghui Yuan
Journal:  Oncotarget       Date:  2017-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.